Connect Biopharma Holdings Ltd ·
CNTB 8-K 2026-09-30
Connect Biopharma Holdings Ltd (CNTB) 8-K dated 2026-09-30 — accession 0001835268-26-000038.
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
Connect Biopharma Holdings Ltd filed a 8-K on 2026-09-30. Accession 0001835268-26-000038.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
Not investment advice. The CNTB SEC hub lists recent forms. The stock page is the research view.